메뉴 건너뛰기




Volumn 15, Issue 4, 2009, Pages 918-925

Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease

(162)  Metjian, A D a,d   Wang, C b   Sood, S L a   Cuker, A a   Peterson, S M c   Soucie, J M b   Konkle, Barbara A a   Boyd, Marjorie e   Roy, Glen e   Forman, Edwin f   Marandola, Jean f   Homans, Alan C g   Granat, Miriam g   Lusher, Jeanne h   Fleming, Patricia h   DiMichele, Donna i   Goldberg, Ilene i   Saidi, Parvin j   Schwartz, Robin j   Desposito, Franklin k   more..


Author keywords

Arthropathy; Factor VIII; Haemorrhage; Von Willebrand disease; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

EID: 67649871214     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02025.x     Document Type: Article
Times cited : (27)

References (21)
  • 1
    • 0036733501 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of von Willebrand disease in Italy
    • Federici AB, Castaman G, Mannucci PM. Guidelines for the diagnosis and management of von Willebrand disease in Italy. Haemophilia 2002; 8: 607-21.
    • (2002) Haemophilia , vol.8 , pp. 607-621
    • Federici, A.B.1    Castaman, G.2    Mannucci, P.M.3
  • 3
    • 33748802581 scopus 로고    scopus 로고
    • Update on the pathophysiology and classification of von Willebrand disease: A report of the subcommittee on von Willebrand Factor
    • Sadler JE, Budde U, Eikenboom JC et.al. Update on the pathophysiology and classification of von Willebrand disease: A report of the subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-14.
    • (2006) J Thromb Haemost , vol.4 , pp. 2103-2114
    • Sadler, J.E.1    Budde, U.2    Eikenboom, J.C.3
  • 4
    • 83055187115 scopus 로고    scopus 로고
    • von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)
    • Nichols WL, Hultin MB, James AH et.al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14: 171-232.
    • (2008) Haemophilia , vol.14 , pp. 171-232
    • Nichols, W.L.1    Hultin, M.B.2    James, A.H.3
  • 5
    • 33646138963 scopus 로고    scopus 로고
    • Genetic diagnosis of haemophilia and other inherited bleeding disorders
    • Peyvandi F, Jayandharan G, Chandy M et al. Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia 2006; 12(Suppl 3): 82-9.
    • (2006) Haemophilia , vol.12 , Issue.SUPPL. 3 , pp. 82-89
    • Peyvandi, F.1    Jayandharan, G.2    Chandy, M.3
  • 6
    • 0033126328 scopus 로고    scopus 로고
    • Hereditary pseudohaemophilia
    • discussion 2
    • Von Willebrand EA. Hereditary pseudohaemophilia. Haemophilia 1999; 5: 223-31; discussion 2.
    • (1999) Haemophilia , vol.5 , pp. 223-231
    • Von Willebrand, E.A.1
  • 7
    • 0014903969 scopus 로고
    • Arthropathy in von Willebrand's disease
    • Ahlberg A, Silwer J. Arthropathy in von Willebrand's disease. Acta Orthop Scand 1970; 41: 539-44.
    • (1970) Acta Orthop Scand , vol.41 , pp. 539-544
    • Ahlberg, A.1    Silwer, J.2
  • 8
    • 33746609245 scopus 로고    scopus 로고
    • Diagnosis of inherited von Willebrand disease: A clinical perspective
    • Federici AB. Diagnosis of inherited von Willebrand disease: A clinical perspective. Semin Thromb Hemost 2006; 32: 555-65.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 555-565
    • Federici, A.B.1
  • 9
    • 0034486136 scopus 로고    scopus 로고
    • Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease
    • Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease. Br J Haematol 2000; 111: 1236-9.
    • (2000) Br J Haematol , vol.111 , pp. 1236-1239
    • Lak, M.1    Peyvandi, F.2    Mannucci, P.M.3
  • 10
    • 0037415123 scopus 로고    scopus 로고
    • Blood safety monitoring among persons with bleeding disorders - United States
    • CDC
    • CDC. Blood safety monitoring among persons with bleeding disorders-United States. Morb MortalWkly Rep 2003; 51: 1152-4.
    • (2003) Morb MortalWkly Rep , vol.51 , pp. 1152-1154
  • 11
    • 12144290833 scopus 로고    scopus 로고
    • Joint range-of-motion limitations among young males with hemophilia: Prevalence and risk factors
    • Soucie JM, Cianfrini C, Janco RL et al. Joint range-of-motion limitations among young males with hemophilia: Prevalence and risk factors. Blood 2004; 103: 2467-73.
    • (2004) Blood , vol.103 , pp. 2467-2473
    • Soucie, J.M.1    Cianfrini, C.2    Janco, R.L.3
  • 12
    • 0020477554 scopus 로고
    • Incidence of severe von Willebrand's disease
    • Weiss HJ, Ball AP, Mannucci PM. Incidence of severe von Willebrand's disease. N Engl J Med 1982; 307: 127.
    • (1982) N Engl J Med , vol.307 , pp. 127
    • Weiss, H.J.1    Ball, A.P.2    Mannucci, P.M.3
  • 13
    • 34547757915 scopus 로고    scopus 로고
    • Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
    • Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
    • (2007) N Engl J Med , vol.357 , pp. 535-544
    • Manco-Johnson, M.J.1    Abshire, T.C.2    Shapiro, A.D.3
  • 14
    • 19944364505 scopus 로고    scopus 로고
    • Long-term prophylaxis in von Willebrand disease
    • Berntorp E, Petrini P. Long-term prophylaxis in von Willebrand disease. Blood Coagul Fibrinolysis 2005; 16(Suppl 1): S23-6.
    • (2005) Blood Coagul Fibrinolysis , vol.16 , Issue.SUPPL. 1
    • Berntorp, E.1    Petrini, P.2
  • 15
    • 33749027736 scopus 로고    scopus 로고
    • Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3
    • Berntorp E. Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3. Semin Thromb Hemost 2006; 32: 621-5.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 621-625
    • Berntorp, E.1
  • 16
    • 33750084376 scopus 로고    scopus 로고
    • The von Willebrand disease prophylaxis network: Exploring a treatment concept
    • Berntorp E, Abshire T. The von Willebrand disease prophylaxis network: exploring a treatment concept. J Thromb Haemost 2006; 4: 2511-2.
    • (2006) J Thromb Haemost , vol.4 , pp. 2511-2512
    • Berntorp, E.1    Abshire, T.2
  • 17
    • 63049088910 scopus 로고    scopus 로고
    • Lower limit of assay sensitivity: An under-recognised and significant problem in von Willebrand disease identification and classification
    • Favaloro EJ, Bonar R, Marsden K. Lower limit of assay sensitivity: An under-recognised and significant problem in von Willebrand disease identification and classification. Clin Lab Sci 2008; 21: 178-85.
    • (2008) Clin Lab Sci , vol.21 , pp. 178-185
    • Favaloro, E.J.1    Bonar, R.2    Marsden, K.3
  • 18
    • 0032860887 scopus 로고    scopus 로고
    • Laboratory testing for von Willebrand's disease: An assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey
    • RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel
    • Favaloro EJ, Smith J, Petinos P, Hertzberg M, Koutts J. Laboratory testing for von Willebrand's disease: An assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel. Thromb Haemost 1999; 82: 1276-82.
    • (1999) Thromb Haemost , vol.82 , pp. 1276-1282
    • Favaloro, E.J.1    Smith, J.2    Petinos, P.3    Hertzberg, M.4    Koutts, J.5
  • 19
    • 33746602713 scopus 로고    scopus 로고
    • Laboratory identification of von Willebrand disease: Technical and scientific perspectives
    • Favaloro EJ. Laboratory identification of von Willebrand disease: technical and scientific perspectives. Semin Thromb Hemost 2006; 32: 456-71.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 456-471
    • Favaloro, E.J.1
  • 20
    • 33746615625 scopus 로고    scopus 로고
    • Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: Results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation
    • Kitchen S, Jennings I, Woods TA, Kitchen DP, Walker ID, Preston FE. Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: Results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation. Semin Thromb Hemost 2006; 32: 492-8.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 492-498
    • Kitchen, S.1    Jennings, I.2    Woods, T.A.3    Kitchen, D.P.4    Walker, I.D.5    Preston, F.E.6
  • 21
    • 33746644201 scopus 로고    scopus 로고
    • An external quality assessment program for von Willebrand factor laboratory analysis: An overview from the European concerted action on thrombosis and disabilities foundation
    • Meijer P, Haverkate F. An external quality assessment program for von Willebrand factor laboratory analysis: An overview from the European concerted action on thrombosis and disabilities foundation. Semin Thromb Hemost 2006; 32: 485-91.
    • (2006) Semin Thromb Hemost , vol.32 , pp. 485-491
    • Meijer, P.1    Haverkate, F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.